Reviews Rifater


No reviews yet.

Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009




Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009




Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009




Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009




Rifater Drug Description
RIFATER®
(rifampin, isoniazid and pyrazinamide) Tablets

WARNING
Severe and sometimes fatal hepatitis associated with isoniazid therapy may occur and may develop even after many months of treatment. The risk of developing hepatitis is age related. Approximate case rates by age are: 0 per 1,000 for persons under 20 years of age, 3 per 1,000 for persons in the 20 to 34 year age group, 12 per 1,000 for persons in the 35 to 49 year age group, 23 per 1,000 for persons in the 50 to 64 year age group, and 8 per 1,000 for persons over 65 years of age. The risk of hepatitis is increased with daily consumption of alcohol. Precise data to provide a fatality rate for isoniazid-related hepatitis is not available; however, in a U.S. Public Health Service Surveillance Study of 13,838 persons taking isoniazid, there were 8 deaths among 174 cases of hepatitis.
Therefore, patients given isoniazid should be carefully monitored and interviewed at monthly intervals. Serum transaminase concentration becomes elevated in about 10% to 20% of patients, usually during the first few months of therapy, but it can occur at any time. Usually enzyme levels return to normal despite continuance of drug, but in some cases progressive liver dysfunction occurs. Patients should be instructed to report immediately any of the prodromal symptoms of hepatitis, such as fatigue, weakness, malaise, anorexia, nausea, or vomiting. If these symptoms appear or if signs suggestive of hepatic damage are detected, isoniazid should be discontinued promptly since continued use of the drug in these cases has been reported to cause a more severe form of liver damage.
Patients with tuberculosis should be given appropriate treatment with alternative drugs. If isoniazid must be reinstituted, it should be reinstituted only after symptoms and laboratory abnormalities have cleared. The drug should be restarted in very small and gradually increasing doses and should be withdrawn immediately if there is any indication of recurrent liver involvement. Treatment should be deferred in persons with acute hepatic diseases.

DRUG DESCRIPTION



What are the possible side effects of isoniazid, pyrazinamide, and rifampin (Rifater)?

If you experience any of the following serious side effects, stop taking isoniazid, pyrazinamide, and rifampin and seek emergency medical attention or contact your doctor immediately:

an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);
excessive tiredness or weakness;
nausea, vomiting, diarrhea, or loss of appetite;
yellow skin or eyes;
unusual bruising or...
Read All Potential Side Effects for Rifater »




RIFATER (rifampin/isoniazid/pyrazinamide) tablets are combination tablets containing 120 mg rifampin, 50 mg isoniazid, and 300 mg pyrazinamide for use in antibacterial therapy. The tablets also contain as inactive ingredients: povidone, carboxymethylcellulose sodium, calcium stearate, sodium lauryl sulfate, sucrose, talc, acacia, titanium dioxide, kaolin, magnesium carbonate, colloidal silicon dioxide, dried aluminum hydroxide gel, ferric oxide, black iron oxide, carnauba wax, white beeswax, colophony, hard paraffin, lecithin, shellac, and propylene glycol. The RIFATER triple therapy combination was developed for dosing convenience.
Rifampin is a semisynthetic antibiotic derivative of rifamycin SV. Rifampin
is a red-brown crystalline powder very slightly soluble in water at neutral
pH, freely soluble in chloroform, soluble in ethyl acetate and methanol. Its
molecular weight is 822.95 and its chemical formula is C43H58N4O12.
The chemical name for rifampin is either:
3-[[(4-methyl-1-piperazinyl) imino]-methyl]-rifamycin;
or
5,6,9,17,19,21-hexahydroxy-23methoxy-2,4,12,16,18,20,22
heptamethyl-8-[N-(4-methyl-1-piperazinyl) formimidoyl]-2,7-(epoxypentadeca
[1,11,13]trienimino)naphtho[2,1-b]furan-1, 11(2H)-dione 21-acetate.
ITS STRUCTURAL FORMULA IS:








Isoniazid is the hydroxide of isonicotinic acid. It is a colorless or white
crystalline powder or white crystals. It is odorless and slowly affected by
exposure to air and light. It is freely soluble in water, sparingly soluble
in alcohol and slightly soluble in chloroform and in ether. Its molecular weight
is 137.14 and its chemical formula is C6H7N3O.
The chemical name for isoniazid is 4-pyridinecarboxylic acid, hydrazide and
its structural formula is:








Pyrazinamide, the pyrazine analogue of nicotinamide, is a white, crystalline
powder, stable at room temperature, and sparingly soluble in water. The chemical
name for pyrazinamide is pyrazinecarboxamide and its molecular weight is 123.11.
Its chemical formula is C5H5N3O and its structural
formula is:







Last reviewed on RxList: 2/13/2009





Other reviews about Rifater on wordpress

Gleevec 2 (in english)
  by Alexandre Nasiasene
Generic Name: imatinib (oral) (im MA ta nib) What is the most important information I should know about Gleevec? Do not use this medication without telling your doctor if you […]


TB (TUBERCULOSIS)
  by ikenya5
TUBERCULOSIS (TB)What is TB (tuberculosis infection)?TB or tuberculosis is a disease caused by a bacterium called Mycobacterium tuberculosis. Mycobacterium tuberculosis belongs to the sub group mycobacterium tuberculosis complex, […]


Zolpidem
  by ykram
What is the most important information I should know about zolpidem? Zolpidem may cause a severe allergic reaction. Stop taking zolpidem and get emergency medical help if you […]


link between singulair and suicide
  by healasthma
SINGULAIR is that suggest a warning to best for my health of S-P?s Claritin (loratadine) and chronic link between singulair and suicide treatment options are widely used to […]


singulair warning
  by healasthma
I've tried tons of an asthma medications in patients less than 12 months of possible connection between the use Singulair without telling your symptoms of the remaining […]


methadone,my anti-drug
  by dhommes4
similar to morphine. It also reduces withdrawal symptoms in people addicted to heroin or other narcotic drugs without causing the "high" associated with the drug addiction. Methadone […]


HIV/AIDS Update - Labeling changes for Kaletra reflecting new QT/QTC interval and PR interval prolongation information
  by neurologist
FDA approved, on April 6, 2009, changes to the product label for Kaletra (lopinavir/ritonavir) Tablets and Oral Solution, reflecting new WARNINGS and PRECAUTIONS regarding QT/QTC interval and PR […]


Drug Store Estrace cream reviews
  by merrilllmasonn
PAIN MEDICATIONS FOR ARTHRITIS The manufacturer pravastatin sodium of aripiprazole recommends reducing the dose of aripiprazole by one-half during ketoconazole therapy. Aripiprazole has not prescription drugs been […]


Tramadol
  by jenlynn401
Tramadol is the pain medication I am on. I began on a low dose and titrated up. When it still was not relieving the pain, my rheumatologist upped […]



Other reviews about Rifater on web:

Learn about the prescription medication Rifater (Rifampin, Isoniazid and Pyrazinamide), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Rifater (Rifampin, Isoniazid and Pyrazinamide) Drug Information ...


Rifater information from Drugs.com. Rifater is a combination antibiotic used to treat the initial phase of tuberculosis. After a 2-month period, your doctor may prescribe another ... Rifater patient advice including side effects


Rifater is a fixed dose combination tablet manufactured by Aventis used in the treatment of tuberculosis. Each tablet contains 120 mg rifampicin, 50 mg isoniazid and 300 mg ... Rifater - Wikipedia, the free encyclopedia


How does it work? This medication contains three different compounds which act together to kill bacteria that cause tuberculosis (TB). Rifampicin targets and inactivates a bacterial ... Rifater Resource Site


Accurate, FDA approved Rifater information for healthcare professionals and patients - brought to you by Drugs.com. Rifater Official FDA information, side effects and uses.


Rifater tablets contain three active ingredients, rifampicin, isoniazid and pyrazinamide. These are all antibiotics used to treat tuberculosis (TB). They work by killing the ... Rifater (rifampicin, isoniazid, pyrazinamide)


Find patient medical information for Rifater Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Rifater Oral : Uses, Side Effects, Interactions, Pictures ...


Easy-Rx-Meds represents you Antibiotics prescription drugs and other meds by discount price. Buy Rifater here online. You can choose Rifater by discount, cheap prices. Antibiotics: Buy Rifater online : Easy Rx Meds. FDA approved ...


Learn about Rifater from the publishers of the Physicians Desk Reference. Find prescription drug information resources including interactions, side effects, symptoms, treatment ... Rifater | Prescription Drug Information, Side Effects | PDRHealth


Buy Generic Rifater (Rifampin/Isoniazid/Pyrazinamide) pills at http://www.easy.md/. Buy Generic Rifater (Rifampin/Isoniazid/Pyrazinamide)





Featured Reviews

Reviews Mifepristone

Mifeprex Drug Description MIFEPREX® (mifepristone) Tablets, 200 mg For Oral Administration Only Serious and sometimes fatal infections and bleeding occur very rarely following spontaneous, surgical, and medical abortions,...
Read More  |  Review This
Reviews Videx EC

Videx EC Drug Description VIDEX EC (didanosine, USP) Delayed-Release Capsules Enteric-Coated Beadlets WARNING: PANCREATITIS, LACTIC ACIDOSIS and HEPATOMEGALY with STEATOSIS Fatal and nonfatal pancreatitis has occurred during therapy...
Read More  |  Review This
Reviews Betapace AF

Betapace AF Drug Description BETAPACE® AF (sotalol HCL) To minimize the risk of induced arrhythmia, patients initiated or re-initiated on BETAPACE AF® should be placed for a minimum of three days (on their maintenance...
Read More  |  Review This
Reviews Entex La

Entex La Drug Description DRUG DESCRIPTION What are the possible side effects of guaifenesin and phenylephrine? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling...
Read More  |  Review This
Reviews Lialda

Lialda Drug Description LIALDA® (mesalamine) Delayed Release Tablets DRUG DESCRIPTION What are the possible side effects of mesalamine oral (Apriso, Asacol, Lialda, Pentasa)? Get emergency medical help if you have any of these...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....